The use of bicyclol in the treatment of severe liver fibrosis: experimental rationale
Aim. To evaluate the antifibrotic effect of bicyclol with promising clinical effects on diffuse parenchymal liver diseases.Materials and methods: We have included 40 adult male Wistar rats (weight, 180 to 200g) with experimentally inducted toxic F3 stage liver fibrosis. Control group consisted of 16...
| الحاوية / القاعدة: | Журнал инфектологии |
|---|---|
| المؤلفون الرئيسيون: | , , , , , , , , , , , |
| التنسيق: | مقال |
| اللغة: | الروسية |
| منشور في: |
Journal Infectology
2021-01-01
|
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://journal.niidi.ru/jofin/article/view/1149 |
